Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric Nolan

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Journal of General Internal Medicine|October 7, 2025
EBM BLS: Self-collected Human Papillomavirus Cervical Cancer Screening Is Non-Inferior to Clinician-Collected SamplesClaire Ruben, Sweta Narasimhan, Eric Nolan
Journal of General Internal Medicine|March 3, 2025
EBM BLS: Ticagrelor without aspirin one month after percutaneous coronary intervention reduces bleeding without worse cardiovascular outcomesEric Nolan, Jessica Ammon, John M Cunningham
Journal of General Internal Medicine|November 21, 2025
EBM BLS: Tirzepatide Remains Effective for Obesity Treatment and Diabetes Prevention at 3 Years of Follow-upJohn M Cunningham, Eric Nolan, Carlos Palacio
Medical Science Educator|July 8, 2025
Navigating the Path Back: A Course for Medical Students Returning from Leave and Their OutcomesEric Nolan, Rakhi Gupta Basuray, Chirag A Patel, et al.
Nature|July 3, 2008
Mouse development with a single E2F activatorShih-Yin Tsai, Rene Opavsky, Nidhi Sharma, et al.
The Journal of Clinical Investigation|January 31, 2017
Dosage-dependent copy number gains in E2f1 and E2f3 drive hepatocellular carcinomaLindsey N Kent, Sooin Bae, Shih-Yin Tsai, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Journal of General Internal Medicine|October 7, 2025
EBM BLS: Self-collected Human Papillomavirus Cervical Cancer Screening Is Non-Inferior to Clinician-Collected SamplesClaire Ruben, Sweta Narasimhan, Eric Nolan
Journal of General Internal Medicine|March 3, 2025
EBM BLS: Ticagrelor without aspirin one month after percutaneous coronary intervention reduces bleeding without worse cardiovascular outcomesEric Nolan, Jessica Ammon, John M Cunningham
Journal of General Internal Medicine|November 21, 2025
EBM BLS: Tirzepatide Remains Effective for Obesity Treatment and Diabetes Prevention at 3 Years of Follow-upJohn M Cunningham, Eric Nolan, Carlos Palacio
Medical Science Educator|July 8, 2025
Navigating the Path Back: A Course for Medical Students Returning from Leave and Their OutcomesEric Nolan, Rakhi Gupta Basuray, Chirag A Patel, et al.
Nature|July 3, 2008
Mouse development with a single E2F activatorShih-Yin Tsai, Rene Opavsky, Nidhi Sharma, et al.
The Journal of Clinical Investigation|January 31, 2017
Dosage-dependent copy number gains in E2f1 and E2f3 drive hepatocellular carcinomaLindsey N Kent, Sooin Bae, Shih-Yin Tsai, et al.
Pageof 1